News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
116 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17551)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4667)
June (3468)
July (2307)
August (2524)
September (2745)
October (3357)
November (3389)
December (2298)
Day
1 (140)
2 (87)
3 (116)
8 (97)
9 (103)
10 (87)
11 (120)
12 (60)
13 (2)
15 (95)
16 (129)
17 (108)
18 (127)
19 (62)
22 (109)
23 (101)
24 (100)
25 (141)
26 (76)
29 (161)
30 (127)
31 (159)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
8
9
10
11
12
13
15
16
17
18
19
22
23
24
25
26
29
30
31
Podcasts
FDA Approves Lilly’s Donanemab While Rejections Highlight Manufacturing Issues
Two CRLs from the FDA last week cited concerns with third-party manufacturers, while Indian CDMOs may make a bid for U.S. business if there is a decoupling from Chinese companies under the BIOSECURE Act.
July 3, 2024
·
1 min read
·
Jef Akst
News
Taysha Shares Positive Rett Results in Bid to Move Past Roadblocks
Taysha Gene Therapies looks to move past its pipeline culls and staff reductions by moving its lead asset into a possible billion-dollar market.
July 3, 2024
·
3 min read
·
Tyler Patchen
Deals
GSK Pays $430M Upfront for CureVac’s COVID-19, Flu mRNA Vaccines
GSK on Wednesday restructured its contract with CureVac to gain access to the biotech’s influenza and COVID-19 programs for $430 million upfront and up to $1.13 billion in future payments.
July 3, 2024
·
2 min read
·
Tristan Manalac
Policy
BIOSECURE Act Erodes Industry Confidence in Chinese Contractors: Report
Despite an uncertain legislative path to becoming law, the BIOSECURE Act has already impacted the biopharma industry’s confidence in Chinese service providers and prompted efforts to diversify manufacturing partners.
July 3, 2024
·
2 min read
·
Tristan Manalac
Drug Development
Endospan Receives Additional $25M From Artivion for Nexus FDA Approval Path
July 3, 2024
·
3 min read
Drug Development
Alafair Biosciences Awarded Synthetic Implantable Products Agreement with Premier, Inc. for VersaWrap® Hydrogel Sheet
July 3, 2024
·
2 min read
Drug Development
Spectral Medical Provides June 2024 Tigris Trial Update
July 3, 2024
·
3 min read
Drug Development
Update: Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products
July 3, 2024
·
12 min read
Drug Development
Artelo Biosciences Announces Data Supporting Broad Potential Utility of its FABP Inhibitor Platform
July 3, 2024
·
7 min read
Business
Accomplished Biotech Leader Michel Dahan Joins Alkeus as President and CEO
July 3, 2024
·
3 min read
Previous
7 of 12
Next
